Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2.
作者信息
Huisman Albert, Beun Robert, Sikma Maaike, Westerink Jan, Kusadasi Nuray
机构信息
Department of Clinical Chemistry and Laboratory Medicine, University Medical Center Utrecht and University Utrecht, Utrecht, The Netherlands.
Department of Intensive Care, University Medical Center Utrecht and University Utrecht, Utrecht, The Netherlands.
出版信息
Int J Lab Hematol. 2020 Oct;42(5):e211-e212. doi: 10.1111/ijlh.13244. Epub 2020 May 22.
Abstract
摘要
相似文献
1
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2.ADAMTS13和血管性血友病因子在感染新型冠状病毒的患者血栓栓塞事件中的作用。
Int J Lab Hematol. 2020 Oct;42(5):e211-e212. doi: 10.1111/ijlh.13244. Epub 2020 May 22.
2
von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.中重度新冠肺炎患者血管性血友病因子/凝血因子Ⅷ裂解酶轴与静脉血栓栓塞症
Br J Haematol. 2021 Mar;192(6):1097-1100. doi: 10.1111/bjh.17216. Epub 2020 Dec 24.
3
Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis.妊娠期 COVID-19 孕妇的产科结局：血管性血友病因子和 ADAMTS13 轴的失衡。
BMC Pregnancy Childbirth. 2022 Feb 21;22(1):142. doi: 10.1186/s12884-022-04405-8.
4
Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients.血管性血友病因子抗原增加和ADAMTS13活性降低与新冠病毒肺炎患者的不良预后相关。
Int J Lab Hematol. 2021 Aug;43(4):O152-O155. doi: 10.1111/ijlh.13476. Epub 2021 Jan 27.
5
Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy.血管性血友病因子/ADAMTS13 失衡在 COVID-19 凝血功能障碍中的作用。
Am J Physiol Heart Circ Physiol. 2022 Jan 1;322(1):H87-H93. doi: 10.1152/ajpheart.00204.2021. Epub 2021 Dec 10.
6
Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU.血管激活是 ICU 中 COVID-19 患者死亡率的一个强有力预测因子。
Blood Coagul Fibrinolysis. 2021 Jun 1;32(4):290-293. doi: 10.1097/MBC.0000000000001007.
7
Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.炎症性肠病中血管性血友病因子及含血小板反应蛋白基序的金属蛋白酶-13的水平与活性
World J Gastroenterol. 2017 Jul 14;23(26):4796-4805. doi: 10.3748/wjg.v23.i26.4796.
8
Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpura.免疫介导的血栓性血小板减少性紫癜缓解期ADAMTS13活性、血管性血友病因子与补体激活之间的相互关系
Br J Haematol. 2020 Apr;189(1):e18-e20. doi: 10.1111/bjh.16415. Epub 2020 Feb 17.
9
Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.蛛网膜下腔出血患者的血浆ADAMTS13活性、血管性血友病因子抗原及活性
Thromb Haemost. 2017 Apr 3;117(4):691-699. doi: 10.1160/TH16-11-0834. Epub 2017 Jan 19.
10
von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support.左心室辅助装置支持下患者体内ADAMTS - 13对血管性血友病因子的蛋白水解作用
J Heart Lung Transplant. 2017 Apr;36(4):477-479. doi: 10.1016/j.healun.2017.01.010. Epub 2017 Jan 13.
引用本文的文献
1
COVID-Induced Thrombotic Thrombocytopenic Purpura: A Case Report and Treatment-Focused Review.新型冠状病毒感染所致血栓性血小板减少性紫癜：1例报告及以治疗为重点的综述
Cureus. 2024 Mar 30;16(3):e57252. doi: 10.7759/cureus.57252. eCollection 2024 Mar.
2
Palmitate Stimulates Expression of the von Willebrand Factor and Modulates Toll-like Receptors Level and Activity in Human Umbilical Vein Endothelial Cells (HUVECs).棕榈酸酯可刺激人脐静脉内皮细胞（HUVEC）中血管性血友病因子的表达，并调节 Toll 样受体的水平和活性。
Int J Mol Sci. 2023 Dec 23;25(1):254. doi: 10.3390/ijms25010254.
3
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID-19 associated with mortality: An updated review.凝血功能障碍和血栓栓塞事件是 COVID-19 相关死亡率的发病机制：最新综述。
J Clin Lab Anal. 2023 Jun;37(11-12):e24941. doi: 10.1002/jcla.24941. Epub 2023 Jul 11.
4
Von Willebrand factor and the thrombophilia of severe COVID-19: evidence from autopsies.血管性血友病因子与重症新型冠状病毒肺炎的血栓形成倾向：尸检证据
Res Pract Thromb Haemost. 2023 May;7(4):100182. doi: 10.1016/j.rpth.2023.100182. Epub 2023 May 18.
5
Endotheliopathy in Acute COVID-19 and Long COVID.急性 COVID-19 和长新冠中的血管内皮病。
Int J Mol Sci. 2023 May 4;24(9):8237. doi: 10.3390/ijms24098237.
6
COVID-19 and Sickle Cell Disease: Two Independent Risk Factors for Venous Thromboembolism.新型冠状病毒肺炎与镰状细胞病：静脉血栓栓塞的两个独立危险因素。
Cureus. 2023 Apr 6;15(4):e37226. doi: 10.7759/cureus.37226. eCollection 2023 Apr.
7
8
Role of the extracellular matrix in COVID-19.细胞外基质在新型冠状病毒肺炎中的作用
World J Clin Cases. 2023 Jan 6;11(1):73-83. doi: 10.12998/wjcc.v11.i1.73.
9
Mild-to-Moderate COVID-19 Convalescents May Present Pro-Longed Endothelium Injury.轻至中度新冠康复者可能存在持续性内皮损伤。
J Clin Med. 2022 Oct 31;11(21):6461. doi: 10.3390/jcm11216461.
10
Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation.SARS-CoV-2 感染的严重程度与肺泡 mast 细胞数量及其脱颗粒有关。
Front Immunol. 2022 Sep 26;13:968981. doi: 10.3389/fimmu.2022.968981. eCollection 2022.
本文引用的文献
1
Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.感染新型冠状病毒（SARS-CoV-2）患者的血栓栓塞事件及明显的肝素抵抗
Int J Lab Hematol. 2020 Jun;42 Suppl 1(Suppl 1):19-20. doi: 10.1111/ijlh.13230.
2
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
3
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
4
von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome.急性缺血性脑损伤发作时的血管性血友病因子/ADAMTS13 比值可预测预后。
Blood Adv. 2020 Jan 28;4(2):398-407. doi: 10.1182/bloodadvances.2019000979.
5
Variation of endothelium-related hemostatic factors during sepsis.脓毒症期间内皮相关止血因子的变化
Microcirculation. 2018 Nov;25(8):e12500. doi: 10.1111/micc.12500. Epub 2018 Oct 10.
6
TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease.血栓性血小板减少性紫癜样综合征：内皮病变相关血管微血栓形成性疾病的新概念与分子发病机制
Thromb J. 2018 Aug 11;16:20. doi: 10.1186/s12959-018-0174-4. eCollection 2018.
7
Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy.弥散性血管内凝血与血栓性微血管病之间的异同
Thromb J. 2018 Jul 11;16:14. doi: 10.1186/s12959-018-0168-2. eCollection 2018.
8
Inflammation, von Willebrand factor, and ADAMTS13.炎症、血管性血友病因子和 ADAMTS13。
Blood. 2018 Jul 12;132(2):141-147. doi: 10.1182/blood-2018-02-769000. Epub 2018 Jun 4.
9
The role of ADAMTS-13 in the coagulopathy of sepsis.ADAMTS-13 在脓毒症凝血障碍中的作用。
J Thromb Haemost. 2018 Apr;16(4):646-651. doi: 10.1111/jth.13953. Epub 2018 Feb 2.
10
The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.血管性血友病因子在血管炎症中的作用：从发病机制到靶向治疗
Mediators Inflamm. 2017;2017:5620314. doi: 10.1155/2017/5620314. Epub 2017 May 28.
Zotero 插件